Skip to main content
. Author manuscript; available in PMC: 2014 Aug 5.
Published in final edited form as: Am J Ophthalmol. 2012 Jan 15;153(4):734–742.e1. doi: 10.1016/j.ajo.2011.09.019

Table 1. Demographic, Medical, and Laboratory Factors for 57 HIV-Infected Study Participants.

Characteristics Summary Statistics
Study site (n [percentage])a
 USC 21 (37%)
 UCLA 36 (63%)
Age (years)
 Mean ± SD 51.9 ± 9.9
 Median (range) 53 (27 to 72)
Male sex (n [percentage])a 56 (98%)
Race/ethnicity (n [percentage])a
 White 31 (54%)
 Black 8 (14%)
 Hispanic 17 (30%)
 Asian 1 (2%)
HIV risk factor, (n [percentage])a,b
 MSM only 41 (75%)
 IDU only 4 (7%)
 Both MSM and IDU 1 (2%)
 Heterosexual 7 (12%)
 IDU and heterosexual 1 (2%)
 Other 1 (2%)
Time since diagnosis of HIV infection (months)
 Mean ± SD 187.1 ± 91.7
 Median (range) 194 (3 to 359)
Diagnosis of AIDS (n [percentage])a 51 (89%)
Time since diagnosis of AIDS (months)
 Mean ± SD 134.4 ± 67.7
 Median (range) 149 (0 to 247)
Current CD4+ T-lymphocyte count (cells/μL)
 Mean ± SD 473.9 ± 226.7
 Median (range) 420 (80 to 1037)
Nadir CD4+ T-lymphocyte count (cells/μL)
 Mean ± SD 118.2 ± 139.8
 Median (range) 66 (0 to 602)
Current HIV blood level (RNA copies/μL)
 Mean ± SD 6011 ± 27816
 Median (range) 0 (0 to 188393)
Smoking history (n [percentage])a
 Current smoker 11 (19%)
 Former smoker 1 (2%)
 Never smoked 45 (79%)
Comorbidities (n [percentage])a
 Hypertension 23 (40%)
 Diabetes mellitus 7 (12%)
 Cardiovascular disease 2 (4%)
 Cerebrovascular accident 0
 Renal disease 3 (5%)

IDU = intravenous drug use; HIV = human immunodeficiency virus; MSM = men who have sex with men; SD = standard deviation.

a

Number of individuals with characteristic among 57 study participants evaluated, unless otherwise stated.

b

HIV risk factor known for 55 of 57 participants.